0001213900-23-097741.txt : 20231221 0001213900-23-097741.hdr.sgml : 20231221 20231221170008 ACCESSION NUMBER: 0001213900-23-097741 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231217 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 180 Life Sciences Corp. CENTRAL INDEX KEY: 0001690080 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813832378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38105 FILM NUMBER: 231506018 BUSINESS ADDRESS: STREET 1: 3000 EL CAMINO REAL STREET 2: BLDG 4, STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-507-0669 MAIL ADDRESS: STREET 1: 3000 EL CAMINO REAL STREET 2: BLDG 4, STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: KBL MERGER CORP. IV DATE OF NAME CHANGE: 20161115 8-K 1 ea190533-8k_180life.htm CURRENT REPORT
false 0001690080 0001690080 2023-12-17 2023-12-17 0001690080 ATNF:CommonStockParValue0.0001PerShareMember 2023-12-17 2023-12-17 0001690080 ATNF:WarrantsToPurchaseSharesOfCommonStockMember 2023-12-17 2023-12-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December 17, 2023

 

180 LIFE SCIENCES CORP.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-38105   90-1890354
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

3000 El Camino Real, Bldg. 4, Suite 200

Palo Alto, CA

  94306
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (650) 507-0669

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   ATNF   The NASDAQ Stock Market LLC
Warrants to purchase shares of Common Stock   ATNFW   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

  

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(a) Resignation of Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray as members of the Board of Directors

 

Effective on December 17, 2023, Francis Knuettel II, Pam Marrone, Teresa DeLuca, Larry Gold, and Russell Ray, resigned as members of the Board of Directors of 180 Life Sciences Corp. (the “Company”).

 

The resignations of Mr. Knuettel II, Ms. Marrone, Ms. DeLuca, Mr. Gold, and Mr. Ray were in connection with a difference of opinion with the Company on cost cutting initiatives. Mr. Knuettel had served as an Audit Committee Member and a Risk, Safety, Regulatory Committee Member prior to his resignation. Ms. Marrone had served as Chairman of the Risk, Safety, Regulatory Committee and as a Compensation Committee Member prior to her resignation. Ms. DeLuca had served as Chair of the Compensation Committee and as a Nominating and Corporate Governance Committee Member prior to her resignation. Mr. Gold has served as Chair of the Nominating and Corporate Governance Committee and as an Audit Committee Member prior to his resignation. Mr. Ray had served as an Audit Committee Member, Compensation Committee Member and Nominating and Corporate Governance Committee Member prior to his resignation.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 21, 2023

 

  180 LIFE SCIENCES CORP.
   
  By:  /s/ James N. Woody, M.D., Ph.D.
    Name:  James N. Woody, M.D., Ph.D.
    Title: Chief Executive Officer

 

 

2

 

 

EX-101.SCH 2 atnf-20231217.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 atnf-20231217_def.xml XBRL DEFINITION FILE EX-101.LAB 4 atnf-20231217_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.0001 per share Warrants to purchase shares of Common Stock Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 atnf-20231217_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Dec. 17, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 17, 2023
Entity File Number 001-38105
Entity Registrant Name 180 LIFE SCIENCES CORP.
Entity Central Index Key 0001690080
Entity Tax Identification Number 90-1890354
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 3000 El Camino Real
Entity Address, Address Line Two Bldg. 4
Entity Address, Address Line Three Suite 200
Entity Address, City or Town Palo Alto
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94306
City Area Code 650
Local Phone Number 507-0669
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock, par value $0.0001 per share  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol ATNF
Security Exchange Name NASDAQ
Warrants to purchase shares of Common Stock  
Title of 12(b) Security Warrants to purchase shares of Common Stock
Trading Symbol ATNFW
Security Exchange Name NASDAQ
XML 7 ea190533-8k_180life_htm.xml IDEA: XBRL DOCUMENT 0001690080 2023-12-17 2023-12-17 0001690080 ATNF:CommonStockParValue0.0001PerShareMember 2023-12-17 2023-12-17 0001690080 ATNF:WarrantsToPurchaseSharesOfCommonStockMember 2023-12-17 2023-12-17 iso4217:USD shares iso4217:USD shares false 0001690080 8-K 2023-12-17 180 LIFE SCIENCES CORP. DE 001-38105 90-1890354 3000 El Camino Real Bldg. 4 Suite 200 Palo Alto CA 94306 650 507-0669 false false false false Common Stock, par value $0.0001 per share ATNF NASDAQ Warrants to purchase shares of Common Stock ATNFW NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 3 24 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://180lifesciences.com/role/Cover Cover Cover 1 false false All Reports Book All Reports atnf-20231217.xsd atnf-20231217_def.xml atnf-20231217_lab.xml atnf-20231217_pre.xml ea190533-8k_180life.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea190533-8k_180life.htm": { "nsprefix": "ATNF", "nsuri": "http://180lifesciences.com/20231217", "dts": { "schema": { "local": [ "atnf-20231217.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "atnf-20231217_def.xml" ] }, "labelLink": { "local": [ "atnf-20231217_lab.xml" ] }, "presentationLink": { "local": [ "atnf-20231217_pre.xml" ] }, "inline": { "local": [ "ea190533-8k_180life.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 27 }, "report": { "R1": { "role": "http://180lifesciences.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-12-17", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea190533-8k_180life.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-17", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea190533-8k_180life.htm", "first": true, "unique": true } } }, "tag": { "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "ATNF_CommonStockParValue0.0001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://180lifesciences.com/20231217", "localname": "CommonStockParValue0.0001PerShareMember", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.0001 per share" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "ATNF_WarrantsToPurchaseSharesOfCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://180lifesciences.com/20231217", "localname": "WarrantsToPurchaseSharesOfCommonStockMember", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase shares of Common Stock" } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://180lifesciences.com/role/Cover" ], "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://180lifesciences.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001213900-23-097741-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-097741-xbrl.zip M4$L#!!0 ( .(E5>_F$4TS , .H. 1 871N9BTR,#(S,3(Q-RYX M63O'J>?9%V5TOKTSQ-R#,HS:5H>U$M] @()F,NQFWO?N!_'EQV MNQ[Y]/'//PC^6G_Y/NEP2.(FN9+,[XJ1_$!N: I-\@4$*&JD^D >:));B>SP M!!2YE&F6@ '<*"PUR5FM'E'B^P?H?0 12W5_VUWHG1B3Z680S&:SFI#/=";5 M5->83 ]3.##4Y'JA+9R'Y>\P^C77;$$.Z.Q,OY_?\J/PVG>2/V?GP=OHN>)'CSDTONG]AD^MSGPG\+DRW-)I!2@I"BVV5@BQ46N$E5/# M[&SD2('D#4/N M6?UO$2MFV;&QKB;F&P5\M3"R&74K6&TK^+W>>EH8N%2&B(U6MN\I*A[1GF1. MU1Z*_?(KGF]%?E3'CER;Z_C5TV.<>#V&XYRH>"-!W&9?[X+;A4NF0XWN M>%CW&MW*"2 QNI*<[,+R,_P_?'!JCG+BYV_[+G=^QG3?^J0D8#(71KT0#NVL8[VVT\ZA<)[@,V2;IU&Y[:=V!&]BG^4ROG// M09PK%Q4.>L5W-7(V8YE2+KH&4HO$4\B'&CMQ;M%?E,QQ,B[4<83L"^Z1*D6% MT7>RGRLVP<[D?-1?1TMQK 9X'.7W!MD*BGS Y7]02P,$% @ XB55[)W MI'$ "0 E6@ !4 !A=&YF+3(P,C,Q,C$W7V1E9BYX;6S57=]SXK86?N_, M_1]\Z3,AD*;MIIMV6#9TF.YNTD!W>_N2$;8 383$2'("__V5_(/86,4B,.4?ZSO?)DHXM.>]_VZZI]X"%))Q==OHGIQT/,Y\'A"TO.W]-N\/I:#+I M>%(A%B#*&;[L,-[Y[=?_?.?IG_?_[7:],<$TN/ ^5T1#^H^/CR>,/Z!'+N[EB<_7]0J<*J1"N2_M='N:_,3N[REA]Q?FUQQ) M[&F^F+S82G+9,?4FU3Z>G7"Q[ U.3_N]OS]_FOHKO$9=P@QO/NZD7J84FU__ MW;MWO>C;U+1@N9T+FM9QUDOA[$O6WP9J[Y U/N_%7V9-24G1&="27,@HDD_< M1RIJ(96(/-#"?.JF9EUSJML?=,_Z)UL9=%*=(K(%I_@6+SSS5PN]K[7_\RDE M"RQ]HMLHCB3N&9O>B.LFK %'WBN!%Y<=I-A"5S(XZP_Z/YDJOL\9J=U&-V5) M3$OL>+U<]4CX*0*;<;86(-B453Y2A"RTU,=IF\0+%%+U[$:9NNROT<"&IZ8RZ*[,DT[ 62\RCV4':7 M"&UZIB/L8:ID>B;J&B,VDQ-W9AC$!H8.&D_TH4PKH&B.:53M76)LL^V]+>H9 MFC\UJ!+$B=TAVB?-AR+%G328FE=EW$HO?,Z4;B57-*I-MW2\- PYT^8:%3!7W[X=;4J=U M%5U>5#;KD%HE4YY]0"(H5HM:;Z5+%N+'9'"&!+'9OJ@2Q7E"E0P@P[P2.23% MX+2=6MSU+ZYDQ>Q@./LROM.9Z9JSJ/8;)**$ M\/3$C-(W6$Q72.#/R=2PH(YQK^G]"GKEYZV %B77 G]>$&"G]MQ>#9#E&Q(" M,25G_"84_DJGCQ$2'4P&;:DT1Y1P9^L'&B//L8& G=V+##P2^R=+_M +,(G[ M.7WPU+WI#W?IW':F2[1HHTVR%G<_O WWU9,P&U"(VQ<91ZJI'6HP@0$TIFAI MYS9GTFARBTA?=<9T!+L?=4(GR$9E9H< R1G+=G!]"!CL+-SV%;=X2:02T1W' M?4#EG8?5I=$B5",')SUNU1@R%B)ZBS=<5(B0M6P%]P7 $.4_N*7\SQ )A07= MU6']P+@5Q-LP0]R?.YZHZ.F5C*BJ0_ZA=2O8MX*&Z/_1+?W3%:;4/"!$K%;K M+]JW0@( -B3"3V\GPM6#F2CHT.KKL'=IG11YY) :/[M50R?>A (_CQFD'Q'&? H%"('K;3G@:P;37\I:)!_1SGO M%5-$[);@PJO?7!E%F(5\9UWK(%?%L @YP[ M2G!C8",-7R Z80'>_H%W9:0?F+: =1MBD'9'B6V,[$:0-1*[*?&K.Y9#VQ80 M;X4,,N\HFXVAS=!V$N@@R(+$:UBK!0!<6J!#&7)0#D?I;(QPPGPN-CQSOWO$ M0WW5[D8\*!T"2AU;($TU?E @1SEOC',8! )+F?PQ /)-X25*7 @4=[9+ !![5PFB:G[22>+M2Y"F++ M]G"?!0QR[C1-3H#=<*D0_8=LJF:G-OOV\%^$#:K@*&M.6H2YC0(MN\J9-)KK M(E*07D>IL1ESA@(CN%EG+9I-[B%0D%M'>>XG;I[JK#@KO8=\:-5HCJU@09Y= MI:MF*YX$NX?]UXUF-H\2HO39VQR.I/2;($KC,2O)0Y;<00*>_%E-&TTUC!BD MW5'*.>64^)HAMORLXQ $43OG1;M&$P[ !=EVE%W>"&S:@-FB&RV&,_MYQ?5B M ?74L'VCV:^ #:K@*,T\@#>1,L3B6"T*7FU2Q X>U,51RCG%?J@[REU_,)^9 MC>I 3W1@U6C>K6!!GAVEF5_X3"#SEIWI;CWG%-["8S%L--L07I!P1QEE#I6= MZIQ)HTDN(@7I=911IA?9U=9?(;;$\(H.FV6CR08!@YP[RC2?.K9EK;YZV::^ M>EFCKW:4:::@XH7Z^KJ[GE.R1/".P!*'5K /X8:$L,7T&D+$^[7,N]O$.D(U MU@=V":RFC28?1@S2[FHK;!@0A8,8X)@PQ'R=S.V# NX05'DU6XPZX$%=G#XG M_88I_8/Q1S;%2'*&@SBQ*'M: ;@T6I%JY* <3I^P>+="B!#BHA=.%Q]&%.M+Q+'GYVH&<80N8+^(%"7>ZWGBZ1I1^"*4.0);V M/SG#%A!>Q L2[G1%\=4:BZ7N!G\7_%&MDHV\9<1;'5H@ (P;%,+IRN&K[=.+ M!>)=C:4J%*S;(($=-,3_N>-MLT/?-TM-XCD!"Y %(#M&ZU!!6Q0!4=I\K5: M89&=E4703#!E"T&JO!JM2"WPH"Y.T^3L:QY*A^6,7:.Y!^"";#O-@F_".27^ MF')4.N_/F+6 ZT.T(-5.,]\/B-V+<*/\W8W@/L;FP9#<7Y,UDJ]:!;1 GOIQ M@,*YW8K[],+.Y!V>H8K^SXI&6WKCHL2O!3)5P@?5(&% M6;PQPUOU05=T7SZYJG1OM%;'10%*EDF]W_<. M35W^OODO/FE_G',/K,_P%0 M2P,$% @ XB55[P%@JWO"P %) !4 !A=&YF+3(P,C,Q,C$W7VQA M8BYX;6S-G6]OV[H5QM\/V'?@O+W8@#J.'6Q#<]M[D:;)17#3)*O==ELQ%+1, M.T)DTJ#DQ/GVXQ])EB@>24Y[2?9%ZTK/H1Z*/Y.4+!Z]^66W3M CX6G,Z-O! M^.AX@ B-V"*FJ[>#3]/AV?3\ZFJ T@S3!4X8)6\'E U^^?F/?T#BSYL_#8?H M,B;)XA2]9]'PBB[93^@&K\DI^I50PG'&^$_H,TZV<@N[C!/"T3E;;Q*2$;%# M'_@4_?UH,L9H..Q1[F="%XQ_^GA5EGN?99OT=#1Z>GHZHNP1/S'^D!Y%;-VO MP&F&LVU:EG:\.\[_Z/ W24P?3N5?_?O#]32Z)VL\C*D\;Q$9%%&R%%O<^/7KUR.UMY VE+LY3XICG(P*.V7) M8F_/35-F[9A'.5+-W'@:!"OF_82$;RDW#\61X,C[:I8M!0L M(1_)$JEJGF;/&X%2&DL2!OFV>TZ6=C,)YR,9/Z)DA3.RD =Z+0\T_H<\T)_S MS==X3I(!DDK!!UBOU[6R\J"1:[-WA,=L<4%?YMJ,]F1??'=X]AT5J,8[K\*, M93AYD?EJI'/;-^1E9WP?Y_Y,BWZ>O.Q,5R)_%]M9T_+!I]=^7A.Y\5I\JEDD MNTP,8&11F)1%M/3 Z@AJ8,C++DMG4:W<1/;FC#?K+D=&5>82IW-5\#8=KC#> MB -,3D8DR=)BRU!N42LA_I;,R_+U2186 M@(K49)RD;,LC)B) 3-D*'GZ:#GY4,L2520O152O_W9K0O M^B4LX8PN%2#CR?B?"I*SV\S)![*> M$V[4[+!0%^B\I#*2HD/BO /U K,-ME2T)NL5VF".'F4)Z"^Z#+01$_Q4EO([ M\?8%1D:.M7K51']7@I_W @ZP_/]U 3JX'.1E[&R9M Z0"J%=XA:;9FHE"+T M5QC\<4"(J2&Y$A\[YU(5H19N%QQ IF3KF_N\MSE@R&SI0H*DQG$# MGXD#+^3!+Q.\LM@W]KMJ8JNMHHUK.X-H9)LCLY5+#9(B7\W\GJ01CS?R%FM; M/6HRYXUN,=EH^XHF+ 2:QF 2*EI/'?M'LHK3C*M[[N6(T]*- 7K777^K;7,L ML(J#@*:/0W"TJ :A,LH31V>4;G'RD6P8;\.G+G--C)2SB)0Z/X 8-NUXY*( X:@[ZT)# MJ'V"<1FG$4ZTETNQS?QYI4/K&A#0K@E)0Q@4*) [$!8=4#"C0KP"\Q^">3]< M*DH_L#2LVE$I90&"8GKKPD3JO4!RON6\YAH><6"I*TRZS!:<0+H@0.DPUW@> M2C5T;ID ;-:A,$0!46%W!F"1BY%2(R'W L8=C]>8/T_CJ&.H: K=H@$9K;-A MJ@*" [ &T)&KT?3JW.=(,L.[JX4 -5[&>HU>!R6@WBTL';;KS #B@-!I=P@0 M)()0/UEXN#2\=<$B ^1\1H;X MQ$1-K&[Y'6>/,8W@*3,D]P(,8-I*C:$-#QV[P2Y^R@EQ$>>UK]&3\LXO22'S MT\O43=J[&*T)#Y*ZL<[.1:M](G''T@PG_XTWK1?B=K$7/*R&K9#4E.&A8K/7 M!8R.02+(QX5UCJO\0<.ZE,S8[^S79INM\B?FZLX@(+ Y:B:WT'=/M,AU,TM& M.<% CU#?[:R1+:;*-J[L"Z.)FX8:+:R^UT+CXXLL,^XE=_>,P@\(-"6N6AHR M5[2VN3^(%@=,F:VN9$CI/-V-EUF_4GOW7=GG;&0W[90#>;$CB-8UW32&Z6*_ MX];\PN-,'%GFF=G2_%<>VW.#@,Y5*[?:+%K<*@JB]=N<-3(":2VJBQUC,65) M',593%^KR M+W;1O3!%@ 4)=IGKKM]FTNS^JYH@$&@QUK@HR:6HT/I8D+ ?LE;=DX"5MTG MJF,2L IQ$K#J.PE8>9L$%(?5*4)$OW0[3^(5!I(3MJI=0]%BV>3#(@T*%=@? MV&>4(6@?XSJCI4IQ)E^9Q-?J^)?B@Z66@,Y93LLVFV522YLH"$;:G#726NJD M ^U:7K6^GZ 8PO)$E^H^R)3@E.&24+?2_%]DM1N][M$S,=MNL/S0#B M('#JXQ!X=$8]D%"K"\CMA7DCZS)(MS3!7:\FYK6<"=&[) 6S6B3%$ 9%B M=P804HJ15OM9H*VS1Y23+/TN2+""D-SQ>W3ZAN,ZR"-?4(G6,#6C68*:A"PD8 MR%R#EH1$\G[+#_![2,H(5(0XIN96,,RKUW'*A'R7'KC:H3O$%4%] MS1<<=>F#H*FG29,I%5:_N%:!ZKV(/K,959/;PU.\FLCQS-ABT)@85Q1!, +: M@J;%U7<%^,F=MYTG<729, S?9:EI'&?,:]HSDN7M!0$1T'0%I?Y>\VV6RA%4&(/O@K<&.?YYH4<%C!\96B("0J^'3>@'A\H; MY5\A'8PJT9ZNS])]%D"R>/?\D2P)E^L.9F27O1,'>FBYPN@1Z_KJK7=US(NY MSL @(#S4+72IEZ)J 6@NGQ'+BT!?92%(E6)[?WEUT[7X)#87F\1?7_ M4$L#!!0 ( .(E5>AJO*B1P@ "]C 5 871N9BTR,#(S,3(Q-U]P M&ULU9UM=]HV%,??[YQ]!X^])CQD7=>L64]*0P^G#\D";;>]Z1&V )T( MB2/)"7S[2083P)9\Z3:NUQJ-)/BLM$Y:S MR+@Y$!/Y:_21S.E%])8*JHB1ZM?H,^&I.R+[C%,5]>1\P:FA]HMUPQ?1L[-N MAT3-)J#>SU0D4GVZ&VSKG1FST!>MUN/CXYF0#^11JGM]%LLYK,*A(2;5V]K: MR_;FW[KX2\[$_87[,2::1I:7T!=+S2X;KMU-LX_G9U)-6]UVN]/ZX\/[83RC M<])DPG&+:2,OY6HI*]=Y\>)%*_LV-RU8+L>*YVV;NX1J&O^/^)@#= M&@2@QXG6-Y.AD?']U9)!XE L\G\,1U'%]K3 "LJN2V_DG##ACT:9;9NJ>&8G;5G;UOT= M_X)A.:H&8&C.<4/S#5#^:7B.G-?E<\F1K;%\6K=O >3^7V'W3S=R[ 6/4;!> MV?83YT.?DVDYUP,3(-@.*ME265AHW]C,2;&% U1!>,\2>U _#G2)2*01XHY. MF4M.G"M;#>$APU,$>^P^:A )RD8*Q940*>%W="%5103V+8'@?ZH%^#*12+Q_ M3XDR5/$5!'G!&$C]62VH>Z1BS4KL[$DS!PI"OF@-1/]S+=#[Q"*Q'\XHY^Z. M.A&@?E]F#^3_O!;\_8)K$('K!S<9L&K@0=@I HS#+[6+0T$V4BAL*LUD8F4H M0! *QD#\+VJ!WR,5%?RU2*#8MZ;@A*I&U ]T(C'O,QT3OO:H;X^5W4K><;W$ M',H>-YNMU(O*_T]*%)C^CC&4/6Z"6Z'UQ.1[J5)[S@0''+\UE#UN:ENE]L3P MKX5A9N56<'Q,/;>'K5G1"@H;-YWUJ4.!G-_,$,:M4 F!/K2$PL;-8D,J48#W MK,.*\(%(Z/(=786(%TRAR'&SUZ!.%.:WBLV)6@U97#V>%&VAU'%SUK!2%.PC MLAPDUFTV8>OE7]7TO46@0D$XI)J3GX*58-(A'06Q/^W>/X=^'\<3/<2KTU MX7]^'/]S.'_<++=2+R;_GOUXHT;RT?/XW&L,98^;Y59HQ22?^7^C;I5\8.NU M\U7X"R6@,:A#\AM6C7H*K&<$D/Z?6T+!UR$1+E>)"?Q6:D/X7VQ1-1$MMX?" MKT-*'%)\ZMN;ZP[@[HOXUDH=F$!!XV;!I;I.S=:%6E'B[]#[%E"RN*EMF:H3 M@WTOW4.9F13!V\)%*RA@W!S5I^[4@[/;GZ:]H\+.U^!%>[A#[Z&>$_/\HIBQ M'KC5W:G8W _R/,#SF$(YXR:609TG9CZ4G,7,,#']8#U7C/!RX&5V4-JX::1? MX8E1WRKJ0NZVJV8KUMS>5G4SF?A&YY ]%#UN%EFM&#<$ ZU3JHX-1$DI:#AP M$TJH^E,/031.[8BXZG3'([==VS, %:R@T'&329^Z$T/^*$>*N/='#%?SL>3^ MG36EAE#4N*EC0..):>_Y4<[YP 1*&#=G+-6%-%Q<+^,9$5/J7XQ1;@DEC9M# MAE2BC<]3T/@\/7)\QLTE?>J0(*_7SMMS[&;,V93X]^<%"X#W*M4"?4#SJ;=' M9MNFW&N(U#SSHV\_E//WF$+)(V]%#>D\-?,T888F:Y?Z3! 1VQQM*\-S Z"Z M%#02R'M5@>I1GCM\H9R_$_)1#"G14M!DG3*$'CUXBT##48?GGA6Z46+Q6?+4 MXE+9:ECE.2L\IE#V=7C>Z=&)LP!UO=9[>WU:OY,NA-Y7 AJ!.CSX#*M&6I)G MJ'NS%WN@;X@A&P]#@?"5@ :B#@]!PZK1-AJHGE4PE>$G_P>&4.QU6!A735O[UKL)@"$JLP:^,J -_KUJLMZ/$L5L7LK[LBX0H#_Z0/30 M]=C ZE=\XA#IP+\K^[HA"JWV&)$E^:U;>@^/)4"%(<&JA[OA +S*(G7RU9!H&WRWGZ[ M^<;]<'_=P![Y&U!+ P04 " #B)57)UK/]NT3 2=0 %P &5A,3DP M-3,S+3AK7S$X,&QI9F4N:'1M[1UI5^+*\KOG^!_Z<=]]QSDCD(1%0(=WD$51 M! 0<=;YXLC30&I*81;DOZ.!BEZP M:1%=^Q;A8UP$84W6%:+UOD4T3\3ME!L%]A,XCH_?7=7:@US4.&9J:O8"NS-6N:Z*[89M<<&MH))@>8X;:9C MA"B7F&&+K#N:;8Z#Y^HUSJ&R3'N9*'@XUZG0J5>:A:S3BPJ\!O1?TYL8JLX?Q)W?T/K -LBHJ"B^-DA+]\B15VSL69'.S"C M")+=3]\B-A[9<=>(XW1"K[@$%+ M81KP7V& -07^MRNJV'OHBJJ%-P'%SX J:R"3<1%@F:):U10\NL3C!PZ<8CK+ M<1EN [CI4V!WZ8%_\!R,BP >;0)#>&CW11-;#\(#\ZG 9$\4X&3^!RD]P,/U(E(?JH4@9CB<].BB,%/ M8I,9C=N#NN.+V,A2(EXS]7#?(A89&"IV?8"' M:AZXB\[2'=/'!MV8C'/>G!%1EN;L^R>_*V83GSR=/"<*;>D2;")&/@YHHL'XO.P& M_]!C8SAO*Z8^F.*8_O4@.Y8-/K.H#P:ZUK9U^:DIFM]%U<%]Z"$'?7Q@?M,\"@HM!+XKA% 4 M'A-8IW?CF(8\2W@@/ &57.8M'G'%3!3A!C5^Y'82A_'PF_Y[8OC1WD T>T3+(2X""8[! MFF=#U):CXFA3[+$(?39*=,=%;=V L0;$L=X#2;?!HWG/AD2Q^S0&Y?Z.S(V6 M=!.(?JJ+\A 0(4RU=)>HJ)(>D""#+\(F3!XFVS,A MR56BLJ[J9@X-^\2&.!Q(NZE7.^42:G<*G7)[)RELEXLWK6JG6FZC0KV$RG?% M\T+]K+R_5VQ<757;[6JCOI-TWQ;:Y]7Z6:=1/T2E6#&&!"Z5S.X>J;YR[A)- MP+Y*HW4%Y%B&J#%/3I/8+">P1#T:+>FR0Y=?6AQYD"=EA&E!X371MGJOUSWK M[(X O/_QR=0HX7XU('R!34JJ'->WDG:9WSXU'\7BAU*,Y]- M)'>/Z%TT(1K8[^_I7=3"AF[:Z( ^0/ 9BQ"U8\2B>U$V+34'*TV]4^%J]U4!5Q+O7("#<$7R?(9#M6JEC-K%:KE> M!)=2;+2:L5#-V%$%.2B/1-EFI7K$3-J?Y?Z>:*&V@65:*U$0T5 13@H2H:%J1K M_E]N?G]B^RGNB:TL9(8+R5\L-4W_7K!I$UE4?9: G"<$)82_@_@5F;>EV022 MHQED@.$;^!-NJ657$(+GRE-_;^M)5E@7AZ,I$(D\6R%-SFB2#"Y."K9Q"F M71%]84[T%:)BX!DL;,%R'K=-O=!6[Z5+\:=2S7)3/P+*<2KY1GO###'>1@0S= MG(D'S%<@W40-NP]AVX5C$DLA,J7\1#+9;B4L=G/NY ,))/ M#RP.IZK2 MBZ$P+[X\A^*:.22"Y]"[_"ZFTY<_"N>;A8[KYP#97=L!JX#\?.D8S%+V];GZ M6P[B51'^;)@=?:@%<^J2Q[7A:SO9YG\N;UU"%\DW155'!=76WRQM+F@&;)%M MF$T(X(DFA^0*9R";9ZL_UAUE&]-8P!G)%PMKA/W[19$+2,'E;BF0Y(.DV-0A M#5-_$",\WWN\*DCB^?WU#T[=A@SG,$((F4QPZ9V*'CTZ:3VD:8*:$4-447F$ M9<\?#J9VHB4V+8/_Y*P,6<&SM[]E8Q49?US#2 M6*A]B$ Q5(2+W3 M(F=Q1/+I5-B:^65I+:AX5-9T4,LF96]TQ&^D- MT"6@R\W7=!>D.3$@5]^1J(W]MBZD*/H0QNWOT=(?H3FLA0Y.2-["V.<;R9]A M#9O@=JL: ')8YHX*,2&&&.U?PAT6AFFD-1O^ON)(B3 M9&_%FA%97ED\"%Q,2!$M:/WH0FJCCG/K*%F./!8<1MIS&+NP1 9.9I0(9CFDYU&S \.CA+I044IX)4=MI0P@" PF(HR#;Z( _0L5*"PD) M+@8=/WEI7^^&_EA"2!K5UMFA7ICR%3AF\,YJL!DL+RULU@F8;/ MMH$I!:!F+@G+!L G19C5C V41W)?U'IXW@*2X)99SS]&L.M&X&_A-TU,?3!] M4X@=;Z,1APFY55@DF;DN)'#WA>?:6[>%<%(^VR: DJ@\0\K:!8)/*E'A0/KB MJMF;S,0=\,=0=MU0CH(-I6I9#C;7FHN:2?.5T_MZ;]C[:'M9HFCWK2:!H\D# M>0.K24 L!@-VW6H^&_U,1.HF?=C$"F1V,PR'+BQ[XZ=NRDL%@=WW]\H4.O$G"/@\I])--WX=8>Z@@274B)?J84'\:-#RW'_P1C M3)&5"]OC@:2K![2 _(LC4!?L.&!P&6 <\F;J559L!*\OERX;W5[%8 M+EQ=XU M:0^&HZJP>CM\6Z^+S^::"[..Y%T@B$$Y!)TVT0L%A/[M@D(&?;>WO^ILWP9[ M+Z$R_(2-E[ 2@.<,7%_PB5I@I(]2Q9[]^&+W/UL+YJ;LOA/]NTNW U',HH2S M"Z;NQY2A1]0_1M"%PLOPII9,E@NK-UZV)NC%T[W4E2\?[ WB2B1?+[1+A>L0 M;7"]!+H2S2=LHUJM^(Y%X/,\/?]AGGZ#^P/ VS_QCS\2JE6Z^#EOO\G]#2L] MO@^(I@2&!PIY-_S ZC^[(/SN7B'L_-J6??Y&^E!,Z?A1:I-G9_5)X _2AP#? M?_N[BSG(^9<^U/EO)/''%GY-DYXT/I4^3^*_>A'89B%F5VLN54VAE2V,I#&2 MV4X_@'O:WQOV,3OMOK #3RP$*@J:15'V$( :^XN7N M.7(I?[-^8<,1GO+91 (=4 X<';-]1[\SH %A&O0%,:_(8^[ON<4V08H* 1#G MBFTNZ.0$-*VY3+\)T5Z.5U:O[%,!_?&4-7=)&% M;-<_%;C3WI'S:JUV->^I-:\@YLUEYG^FPE2[ 88_41MZ@"W(C_C'@F8\"/A\ MA%4LV^ D-)T5=1T(WF@O(,@[*41OA"6LT.O>\42%R[R,.J;8AP2<#M56#>9* M78.)7X@% \'WB)I,]WY%F=V 2GO3^W@5T50LQ,X(402!)>7$@3A?4I[U*3&/ M_^\UCXER?8(6+=SZ\!F:\XMO19JY]2BP^#AS:]+V;D7:+O]^G93H[(X!R+-# MM[P ESM5%NRE@$C9$TW9,5BLO$1->L/UD3L,R,A]&K3JWW<(6C)X<>*V8=/VRT*7F8-O&*JI6 M#\% !_M[D*R8NH:!( SYD@@BK#FR>(AJ\'R,SG15.80E40&?:UE855%+9/'X M@.52EA\QG^JP$,X)\I-6I,\)7^9.UW(Q=J:BW.U2_7UAVT"SEZ_L[]'P\3"4 MY^@=+#^$4(<*%&*,MS"?92H9;G^O1KJ0SGB7CX/EF$8,'= Q]*4!82'N6*5/ M7C3K296-YH\_.L_YE>+ML/!R8D2,I5=F;"+-_3TJSBLK-A4G_>#+DG:=2I)^ MHH8S!('3%!;R#9?$4OI$U"+6$_!,[&(; ME*V%>X[J.MBE_@8$SB8-<&G".\.AV"PS]O?FT1?[(H$T:G+X_@WH&%U ^-3? M4XZL( <^+)*SO^?* P50XY,2 GZ"ON[>!\K>H8%G1>]M? SB?<$FS0OP!E2Y M0J*:P3*6$)HVP^F3&BKB4)&YU%#-?*.V'*Z1!B7E/0RC[UF$T/BK#M]L^8:[ M=Q,QAWY%>"TJ%ST]K6G;F[_+;;' F^ M@0 :"?=%M4O+:P!H?X^%?%X/6+NPH\$@!D]T[+YNDE>L;-,E?YZ\5EX5F9M& M\ +O7Y_XZ9/<\0.>;]JD#-G5!& T<_@62;SAM%WHM87O.ELWJZ D'X5:P4@_RT M#[_HNZW;.;_BJ5Z:EEI7[7;[UTB\K5OJ[W5S9!'#*K[. TSP:R&N9-?6=?(] MFL3.L.0"I[MF9+%/<'?I\@CSHW>OPYW\\A<#+'59&W NAYN1O+ 2U:_=:IB- MOC_R*Q;\2<;IEY7EV;?BV0,U_\:O1LN-^.E7JN&+$?^D5)X+C^7K MEA0O=$?DMJGK@Z>;V@\[(8YNGDU@2^UH\)Q^K4M$NFW_^/&'+?5D\'FN M^LA).'Y]/3"2U9O&5]U.'@F%KZ^IVNG51>KT:E!_'KP6^.;=,W=^K76*CMU+ M)1]E^S;C[ZHKG?U!+ 0(4 Q0 ( M .(E5>_F$4TS , .H. 1 " 0 !A=&YF+3(P,C,Q M,C$W+GAS9%!+ 0(4 Q0 ( .(E5>R=Z1Q D )5H 5 M " ?L# !A=&YF+3(P,C,Q,C$W7V1E9BYX;6Q02P$"% ,4 " #B)57 MO 6"K>\+ 4D %0 @ $N#0 871N9BTR,#(S,3(Q-U]L M86(N>&UL4$L! A0#% @ XB55Z&J\J)'" +V, !4 M ( !4!D &%T;F8M,C R,S$R,3=?<')E+GAM;%!+ 0(4 Q0 ( .(E5